The adrenergic antagonist improved near vision in adults with presbyopia, with over 20 hours of improvement from a single administration in the VEGA-3 trial. Medscape Medical News
Author: Medscape
Postmenopausal HRT Tied to Glaucoma Risk in Women
The use of postmenopausal hormone replacement therapy is associated with an increased risk for glaucoma in Finnish women aged 50 years or older, according to a recent nested case-control study. Medscape Medical News
Sedation-Free Cataract Surgery Feasible for Select Patients
In a retrospective case series, surgical control and safety are maintained without systemic anesthesia, showing feasibility to expand use. Medscape Medical News
Eye Shingles Tied to Cancer Risk in Those With Immune Issues
Herpes zoster ophthalmicus is associated with an increased risk for subsequent malignancy among individuals with an underlying history of immune dysregulation, according to a recent cohort study. Medscape Medical News
Cosmetic Eyelash Extensions Linked to Dry Eye Symptoms
Eye symptoms affect most recipients of lash lifts and extensions, with an independent association with dry eye in an observational study. Medscape Medical News
ASCRS 2026
Read clinically focused news coverage of key developments from ASCRS 2026 Medscape Ophthalmology
Insurers Fail to Get Specific on Prior Authorization Reforms
An industry trade group says prior authorization requirements have declined by 11% after last year’s pledge, but the numbers are fuzzy. Medscape Medical News
IDEAYA and Servier’s Eye Cancer Drug Meets Trial Goal, Paving Way for FDA Application
IDEAYA Biosciences and French pharma company Servier said on Monday their combination drug for a type of eye cancer met the main goal of a mid-to-late-stage trial, sending… Reuters Health Information
Should Your Patient Be on Statins? Maybe the Eyes Can Tell
A trial of an AI algorithm that uses retina images to evaluate the risk for atherosclerotic cardiovascular disease demonstrates a high level of accuracy. Medscape Medical News
Medscape Physician Compensation Report 2026: Positive Signs
US physicians report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed. Medscape
Treating IgG4-RD: How Far Will B-Cell Drugs Take the Field?
Post hoc analyses of pivotal MITIGATE trial show broad efficacy across patient subgroups with differing organ involvement and clinical characteristics. Medscape Medical News
Docs, Lawsuit Challenge Medicare WISeR Prior Auth Experiment
Doctors in multiple states report unpaid claims and care delays under the new federal program, as a lawsuit seeks answers about AI algorithms and data security. Medscape Medical News
Sarcoid Uveitis: 1 in 3 Achieve Remission, Relapses Rare
Remission is achievable and relapses are uncommon in patients with sarcoid uveitis, although those with swelling in the macular region may experience delayed remission. Medscape Medical News
GLP-1 Drugs Under Scrutiny: How Real Are the Risks?
Gastrointestinal adverse effects remain a key barrier to continued use of these agents, with slower dose titration emerging as a strategy to improve tolerability and adherence. Medscape News Europe
Myopia Numbers Are Rising. Our Response Should Be Too
With myopia affecting 1 in 3 people, eye experts are urging clinicians to act now to slow progression in patients. Medscape Medical News
Female Eye Doctors Earn Less Across All Ranks
Women in academic ophthalmology earn less than men across all ranks, with a pay-gap over a full career of roughly $1 million, a study finds. Medscape Medical News
Myth of the Month: GLP-1s Have Many Dangerous Side Effects
Dr Paauw debunks concerns about thyroid cancer, suicide, and pancreatitis. Medscape Internal Medicine
Vascular Complications Tied to Poor CRC Outcomes in Diabetes
In patients with colorectal cancer undergoing major resection surgery, a greater severity of diabetes-related vascular complications is linked to poorer postoperative outcomes, including mortality. Medscape News UK
Immunovant’s Treatment for Eye Disease Fails in Late-stage Trials
Immunovant said on Thursday that its therapy failed to reduce eye bulging when tested in patients with moderate-to-severe thyroid eye disease in two late-stage… Reuters Health Information
The Death of the Medical Fax Is Foretold — Again
Medical offices are sick and tired of faxing, and federal officials agree. But modernization won’t be easy. Medscape Medical News